Insider Trading Activity For Kala Pharmaceuticals Inc (NASDAQ:KALA)

Associates L.L.C. Cdk , Major Shareholder of Kala Pharmaceuticals Inc (NASDAQ:KALA) reportedly Bought 215,000 shares of the company’s stock at an average price of 15 for a total transaction amount of $3,225,000.00 SEC Form

Analyst Ratings For Kala Pharmaceuticals Inc (NASDAQ:KALA)
These are No ratings tracked in the last 12 months. .
The current consensus rating for Kala Pharmaceuticals Inc (NASDAQ:KALA) is N/A (Score: NaN) with a consensus target price of N/A

Recent Trading Activity for Kala Pharmaceuticals Inc (NASDAQ:KALA)
Shares of Kala Pharmaceuticals Inc closed the previous trading session at with shares trading hands.